EMEA-001438-PIP01-13-M01

Key facts

Invented name
Praxbind
Active substance
idarucizumab
Therapeutic area
Other
Decision number
P/0151/2019
PIP number
EMEA-001438-PIP01-13-M01
Pharmaceutical form(s)
Solution for injection/infusion
Condition(s) / indication(s)
  • Prevention of dabigatran associated haemorrhage
  • Treatment of dabigatran associated haemorrhage
Route(s) of administration
Intravenous use
Contact for public enquiries
Boehringer Ingelheim International GmbH 

Tel. +49 6132 7782 71 
E-mail: paediatrics@boehringer-ingelheim.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating